NCT07591714 The Effect of Intradialytic Eye Exercise in Hemodialysis Patients
| NCT ID | NCT07591714 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pardis Specialized Wellness Institute |
| Condition | End Stage Renal Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-06-01 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-06-01 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot randomized trial will evaluate whether a structured intradialytic eye-exercise program can be delivered safely and consistently during maintenance hemodialysis and whether it shows preliminary promise for improving physical function, balance, and fall-related concern. The study is needed because hemodialysis patients commonly experience impaired physical performance, reduced balance, and fear of falling, and these problems are associated with higher fall risk; at the same time, supervised exercise during dialysis is increasingly viewed as a practical way to reach this medically complex and often sedentary population. Eye-movement and gaze-stability training has also shown benefit for balance- and fall-related outcomes in older adults and stroke survivors, but its feasibility and potential value during dialysis sessions remain uncertain.
Eligibility Criteria
Inclusion Criteria * Adults ≥18 years receiving maintenance in-center hemodialysis * Clinically stable for brief seated intradialytic intervention * Able to understand and follow eye-exercise instructions * Able to provide informed consent * Able to sit upright independently during dialysis * Able to complete repeated outcome assessments * Able to communicate discomfort or adverse symptoms * Usual corrective lenses permitted if needed for visual clarity Exclusion Criteria * Unstable cardiac conditions (e.g., unstable angina, recent myocardial infarction, decompensated heart failure, uncontrolled arrhythmia) * Active infection or acute medical illness * Hemodynamic instability * Significant cognitive or communication impairment preventing instruction-following * Severe uncorrected visual impairment or active ocular disease * Recent major ophthalmologic surgery * Severe musculoskeletal or neurologic limitations preventing participation or testing * Any condition deemed unsafe for intradialytic exercise by the treating physician or nephrologist
Contact & Investigator
Mohammad Ali Tabibi, Dr
STUDY DIRECTOR
Study Director Pardis Specialized Wellness Institute
Frequently Asked Questions
Who can join the NCT07591714 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying End Stage Renal Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07591714 currently recruiting?
Yes, NCT07591714 is actively recruiting participants. Contact the research team at statisrin@gmail.com for enrollment information.
Where is the NCT07591714 trial being conducted?
This trial is being conducted at Isfahan, Iran.
Who is sponsoring the NCT07591714 clinical trial?
NCT07591714 is sponsored by Pardis Specialized Wellness Institute. The principal investigator is Mohammad Ali Tabibi, Dr at Study Director Pardis Specialized Wellness Institute. The trial plans to enroll 30 participants.